Stock listing

gettex:CYL Artivion, Inc. Aktie

German listing (gettex) of Artivion, Inc. · home listing NYSE:AORT

Follow Artivion, Inc. into a list and get an email when it puts out news.

Home listing price · NYSE:AORT

$18.16 USD -0.38 (-2.0%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NYSE:AORT

Past year -58.8% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$18.13 – $18.93 USDNov 20, 2026
Volume
642,096 sharesNov 20, 2026
Market cap
$886.0M USDAt the close on Nov 20, 2026 · price × 48.79M shares outstanding
52-week range
$18.12 – $48.25 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$15.47M USDMedian day 561,739 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Artivion, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NYSE:AORT · Home$18.16 USD-0.38 (-2.0%)642,096$18.52$18.93$18.13$18.54Close on Nov 20, 2026
Frankfurt:CYL€16.70 EUR-0.30 (-1.8%)—€16.70€16.70€16.70€17.00Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NYSE:AORT · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$18.16-0.38-2.0%$18.52$18.93$18.13642,096
$18.54+0.27+1.5%$18.17$18.77$18.17913,922
$18.27-0.20-1.1%$18.19$18.68$18.13561,739
$18.47-0.63-3.3%$19.27$19.33$18.12523,784
$19.10-0.30-1.5%$19.62$19.81$18.95557,998
$19.40-0.70-3.5%$20.06$20.77$19.20855,181
$20.10-0.37-1.8%$20.25$20.73$20.05646,227
$20.47-0.17-0.8%$20.43$20.68$19.21997,934
$20.64+0.43+2.1%$20.32$21.06$19.331,662,766
$20.21-5.12-20.2%$22.19$23.01$19.743,247,000
$25.33-1.12-4.2%$26.93$27.00$24.691,127,700
$26.45+2.74+11.6%$24.45$26.69$24.451,086,400
$23.71+0.13+0.6%$23.56$23.94$23.22645,700
$23.58+1.00+4.4%$22.87$23.93$22.82626,200
$22.58-0.86-3.7%$23.62$23.62$21.85627,400
$23.44+0.52+2.3%$23.80$23.80$23.05418,200
$22.92-0.02-0.1%$22.59$23.38$22.59421,600
$22.94-0.04-0.2%$22.98$23.15$22.61405,200
$22.98-0.32-1.4%$23.12$23.63$22.91366,000
$23.30-0.67-2.8%$23.86$24.20$22.91415,300
$23.97+1.07+4.7%$23.03$24.24$23.03544,400
$22.90-0.19-0.8%$22.76$23.31$22.69473,800
$23.09+0.81+3.6%$22.95$23.69$22.81631,100
$22.28+0.50+2.3%$21.68$22.51$21.52465,100
$21.78-0.09-0.4%$21.83$22.37$21.64433,600
$21.87+0.34+1.6%$22.02$22.49$21.53512,500
$21.53+0.17+0.8%$21.32$21.75$21.08488,500
$21.36-0.43-2.0%$21.83$22.40$21.30664,600
$21.79+0.53+2.5%$21.21$21.91$21.09436,600
$21.26+0.05+0.2%$21.15$21.60$20.21343,500
$21.21-0.40-1.9%$21.45$21.45$20.89602,200
$21.61-0.23-1.1%$21.80$22.40$21.59352,000
$21.84-0.77-3.4%$22.83$23.31$21.65494,300
$22.61+0.30+1.3%$22.21$23.04$22.16734,200
$22.31+0.38+1.7%$22.07$22.72$21.60559,400
$21.93-0.89-3.9%$22.87$23.11$21.86501,700
$22.82-0.04-0.2%$22.91$23.11$22.64501,400
$22.86-0.09-0.4%$22.90$23.07$22.41336,500
$22.95+0.32+1.4%$22.63$23.21$22.42446,100
$22.63-0.40-1.7%$23.06$23.30$22.52502,800
$23.03-0.50-2.1%$23.59$23.72$23.00567,200
$23.53-0.60-2.5%$24.15$24.76$23.03504,000
$24.13+0.50+2.1%$23.93$24.15$23.44605,400
$23.63+0.28+1.2%$23.27$23.72$22.92569,100
$23.35-0.53-2.2%$23.80$24.26$23.301,914,800
$23.88-1.14-4.6%$24.96$25.14$23.71572,600
$25.02-0.36-1.4%$25.33$25.48$24.96683,200
$25.38+0.41+1.6%$24.89$25.75$24.40949,000
$24.97-0.11-0.4%$25.61$25.74$24.83599,000
$25.08+0.43+1.7%$24.96$25.28$24.40547,900
$24.65-0.57-2.3%$25.12$25.40$24.50694,500
$25.22+0.09+0.4%$25.15$25.72$24.72553,800
$25.13-0.44-1.7%$25.42$25.81$24.92619,400
$25.57-0.05-0.2%$25.37$25.69$25.18418,300
$25.62-0.72-2.7%$26.50$26.90$25.45438,800
$26.34-0.75-2.8%$26.93$27.92$26.29549,500
$27.09+0.10+0.4%$27.05$27.95$26.92675,100
$26.99+0.22+0.8%$26.46$27.10$25.86669,100
$26.77+0.10+0.4%$26.71$27.11$26.69466,500
$26.67-0.53-1.9%$26.92$27.34$26.58440,800
$27.20+0.82+3.1%$26.18$27.42$26.02609,000
$26.38-0.51-1.9%$26.89$27.15$26.19735,700
$26.89-1.19-4.2%$28.01$28.17$26.771,036,000
$28.08+0.10+0.4%$27.86$28.61$27.82484,900
$27.98-0.84-2.9%$28.49$29.01$27.77819,300

Splits

2 splits since 1996 · NYSE:AORT · every price before a split is adjusted for it

DayRatioWhat
3-for-2Split
2-for-1Split
Ticker
gettex:CYL
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
gettex
Currency
EUR

What changed lately

Latest news

All Artivion, Inc. news

Artivion, Inc. on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
15 in the last 12 months · 31 in all · newest Nov 5, 2026 · oldest 2025
Calls
32 calls with a replay · 32 with a transcript · latest Nov 5, 2026
Decks
14 decks · latest Aug 6, 2026

Where Artivion, Inc. is listed

ListingExchangeCountryCurrency
NYSE:AORT · Home listingNYSEUnited StatesUSD
gettex:CYL · This pagegettexGermanyEUR
LS Exchange:900006LS ExchangeGermanyEUR
Lang & Schwarz:900006Lang & SchwarzGermanyEUR
BOATS:AORTBOATSUnited StatesUSD
Frankfurt:CYLFrankfurtGermanyEUR
Hamburg:CYLHamburgGermanyEUR
Dusseldorf:CYLDusseldorfGermanyEUR
Stuttgart:CYLStuttgartGermanyEUR
Tradegate:CYLTradegateGermanyEUR

Valuation

EV/sales 2.5× against a median of 2.8×: 6th lowest of 11 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$1.20B USD
P/E
Loss
EV/sales
2.5×
EV/EBITDA
32.3×
Price/book
2.0×
Gross margin
63.3%
Operating margin
2.3%
Net margin
−3.6%
Debt to equity
0.8×
Beta vs S&P 500
0.42

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Artivion, Inc. · NYSE:AORTUS$886.0MUS$1.20Bn/a2.5×32.3×2.0×−3.6%0.8×0.42
Shenzhen Edge Medical Co., Ltd. Class H · HKEX:2675US$973.0MUS$695.3Mn/a10.2×n/a2.8×−19.4%0.0×n/a
Anhui Hongyu Wuzhou Medical Manufacturer Co., Ltd. Class A · SZSE:301234US$952.4MUS$890.2M354×14.4×n/a8.3×4.3%0.0×n/a
Edan Instruments, Inc. Class A · SZSE:300206US$939.7MUS$748.4M16.9×2.3×n/a2.7×17.1%0.0×n/a
Arjo AB Class B · OMXSTO:ARJO_BUS$904.9MUS$1.35B25.6×1.2×6.8×1.1×3.3%0.7×n/a
Kuros Biosciences Ltd. · SIX:KURNUS$889.2MUS$892.9M352×6.2×74.9×10.4×1.8%0.1×n/a
Hartalega Holdings Bhd. · MYX:HARTAUS$870.5MUS$585.7M20.4×1.1×6.0×0.8×7.6%0.0×n/a
OrthoPediatrics Corp. · NASDAQ:KIDSUS$828.7MUS$889.1Mn/a3.4×n/a2.4×−12.8%0.3×0.78
Modern Dental Group Limited · HKEX:3600US$819.4MUS$791.3M10.8×1.7×7.1×1.8×16.0%0.2×n/a
Aidite (Qinhuangdao) Technology Co., Ltd. Class A · SZSE:301580US$818.5MUS$614.5M27.1×3.5×n/a2.4×17.4%0.0×n/a
Zhonghong Pulin Medical Products Co., Ltd. Class A · SZSE:300981US$818.2MUS$309.6M36.8×0.8×n/a1.0×5.4%0.0×n/a
Median of the othersUS$879.8MUS$769.8M26.3×2.8×7.0×2.4×4.9%0.0×0.78

Forecasts

7 strong buy · 2 buy · Analysts' consensus from EODHD, read Nov 19, 2026. Not 6ix's view and not investment advice.

Price target
38.47 USD · Analysts' mean
EPS, year to Dec 2026
0.37 · 6 analysts
Revenue, year to Dec 2026
489.3M · 9 analysts

Team and board

Officers

OfficerRole
J. Patrick MackinChairman, President and Chief Executive Officer
Marna P. BorgstromChief Executive Officer
Lance BerryExecutive Vice President, Chief Operating Officer, and Chief Financial Officer
Thomas F. AckermanExecutive Vice President and Chief Financial Officer
Jean F. HollowaySenior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary
Amy D. HortonVice President, Chief Accounting Officer
Andrew M. GreenSenior Vice President, Regulatory and Quality
Brian JohnstonExecutive Vice President
Carlos SotoVice President, Global Manufacturing
Jason AsperSenior Vice President and Chief Strategy and Digital Officer
Matthew A. GetzVice President, Chief Human Resources Officer
Robert C. ThomsonVice President, Research and Development
Rochelle L. ManeyVice President, Global Quality
Simona ZannettiSenior Vice President of Clinical Research and Chief Medical Officer
Elizabeth A. HoffConsultant and Founder
John E. DavisChief Commercial Officer

Board

DirectorRole
J. Patrick MackinChairman, President and Chief Executive Officer
Jon W. SalvesonVice Chairman, Investment Banking
Anthony SemedoDirector
Daniel J. BevevinoDirector
Elizabeth A. HoffConsultant and Founder
Jeff BurbankLead Director
Marna P. BorgstromChief Executive Officer
Thomas F. AckermanExecutive Vice President and Chief Financial Officer

Events

Calls

CallWhenStatus
Artivion (NYSE:AORT) Q3 2026 Earnings CallThu, Nov 05, 2026 · 4:30 PM ETReplay
Artivion (NYSE:AORT) Q2 2026 Earnings CallThu, Aug 06, 2026 · 4:30 PM ETReplay
Artivion (NYSE:AORT) Q1 2026 Earnings CallThu, May 07, 2026 · 4:30 PM ETReplay
Artivion (NYSE:AORT) Q4 2025 Earnings CallThu, Feb 12, 2026 · 4:30 PM ETReplay
Artivion (NYSE:AORT) Q3 2025 Earnings CallThu, Nov 06, 2025 · 4:30 PM ETReplay
Artivion (NYSE:AORT) Q2 2025 Earnings CallThu, Aug 07, 2025 · 4:30 PM ETReplay
Artivion (NYSE:AORT) Q1 2025 Earnings CallMon, May 05, 2025 · 4:30 PM ETReplay
Artivion (NYSE:AORT) Q4 2024 Earnings CallMon, Feb 24, 2025 · 4:30 PM ETReplay
Artivion (NYSE:AORT) Q3 2024 Earnings CallThu, Nov 07, 2024 · 4:30 PM ETReplay
Artivion (NYSE:AORT) Q2 2024 Earnings CallThu, Aug 08, 2024 · 4:30 PM ETReplay
All 32 calls
CallWhenStatus
Artivion (NYSE:AORT) Q1 2024 Earnings CallMon, May 06, 2024 · 4:30 PM ETReplay
Artivion (NYSE:AORT) Q4 2023 Earnings CallThu, Feb 15, 2024 · 4:30 PM ETReplay
Artivion (NYSE:AORT) Q3 2023 Earnings CallThu, Nov 02, 2023 · 4:30 PM ETReplay
Artivion (NYSE:AORT) Q2 2023 Earnings CallThu, Aug 03, 2023 · 4:30 PM ETReplay
Artivion (NYSE:AORT) Q1 2023 Earnings CallThu, May 04, 2023 · 4:30 PM ETReplay
Artivion (NYSE:AORT) Q4 2022 Earnings CallThu, Feb 16, 2023 · 4:30 PM ETReplay
Artivion (NYSE:AORT) Q3 2022 Earnings CallThu, Nov 03, 2022 · 4:30 PM ETReplay
Artivion (NYSE:AORT) Q2 2022 Earnings CallThu, Aug 04, 2022 · 4:30 PM ETReplay
Artivion (NYSE:AORT) Q1 2022 Earnings CallThu, May 05, 2022 · 4:30 PM ETReplay
Artivion (NYSE:AORT) Q4 2021 Earnings CallThu, Feb 17, 2022 · 4:30 PM ETReplay
Artivion (NYSE:AORT) Q3 2021 Earnings CallThu, Nov 04, 2021 · 4:30 PM ETReplay
Artivion (NYSE:AORT) Q2 2021 Earnings CallThu, Jul 29, 2021 · 4:30 PM ETReplay
Artivion (NYSE:AORT) Q1 2021 Earnings CallThu, Apr 29, 2021 · 4:30 PM ETReplay
Artivion (NYSE:AORT) Q4 2020 Earnings CallThu, Feb 11, 2021 · 4:30 PM ETReplay
Artivion (NYSE:AORT) Q3 2020 Earnings CallWed, Nov 04, 2020 · 4:30 PM ETReplay
Artivion (NYSE:AORT) Q2 2020 Earnings CallThu, Jul 30, 2020 · 4:30 PM ETReplay
Artivion (NYSE:AORT) Q1 2020 Earnings CallThu, Apr 30, 2020 · 4:30 PM ETReplay
Artivion (NYSE:AORT) Q4 2019 Earnings CallThu, Feb 13, 2020 · 4:30 PM ETReplay
Artivion (NYSE:AORT) Q3 2019 Earnings CallWed, Oct 30, 2019 · 5:30 PM ETReplay
Artivion (NYSE:AORT) Q2 2019 Earnings CallTue, Jul 30, 2019 · 4:30 PM ETReplay
Artivion (NYSE:AORT) Q1 2019 Earnings CallTue, Apr 30, 2019 · 4:30 PM ETReplay
Artivion (NYSE:AORT) Q4 2018 Earnings CallThu, Feb 14, 2019 · 8:30 AM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 5, 2026 · After close−20.2%
Q2 2026Aug 6, 2026 · After close+2.1%
Q1 2026May 7, 2026 · After close−28.3%
Q4 2025Feb 12, 2026 · After close−10.0%
Q3 2025Nov 6, 2025 · After close−5.5%
Q2 2025Aug 7, 2025 · After close+25.2%
Q1 2025May 5, 2025 · After close+15.4%
Q4 2024Feb 13, 2025 · Before open+1.0%
Q3 2024Nov 7, 2024 · After close−0.9%
Q2 2024Aug 8, 2024 · After close−1.9%
All 20 quarters
QuarterResultsShare move
Q1 2024May 6, 2024 · After close+12.8%
Q4 2023Feb 15, 2024 · After close+4.3%
Q3 2023Nov 2, 2023 · After close+9.9%
Q2 2023Aug 3, 2023 · After close−1.6%
Q1 2023May 4, 2023 · After close+13.8%
Q4 2022Feb 16, 2023 · After close+5.8%
Q3 2022Nov 3, 2022 · After close−1.9%
Q2 2022Aug 4, 2022 · After close−2.6%
Q1 2022May 5, 2022 · After close−4.3%
Q4 2021Feb 17, 2022 · After close+1.4%

Open Events

Decks

DeckKindSlidesDate
Q2 2026 Earnings PresentationEarnings22 slidesAug 6, 2026
Investor Presentation (August 2026)Investor deck23 slidesAugust 2026
Q1 2026 Earnings PresentationEarnings20 slidesMay 7, 2026
Investor Presentation (May 2026)Investor deck20 slidesMay 2026
Q4 2025 Earnings PresentationEarnings22 slidesFeb 12, 2026
Q2 2025 Earnings PresentationEarnings19 slidesAug 7, 2025
Q1 2025 Earnings PresentationEarnings20 slidesMay 5, 2025
Q3 2024 Earnings PresentationEarnings16 slidesNov 7, 2024
Q2 2024 Earnings PresentationEarnings16 slidesAug 8, 2024
Q1 2024 Earnings PresentationEarnings17 slidesMay 6, 2024
All 14 decks
DeckKindSlidesDate
Investor Presentation (December 2020)Investor deck28 slidesDec 7, 2020
Cryolife — Investor Presentation (February 2016)Investor deck44 slidesFeb 16, 2016
Cryolife — Investor Presentation (November 2011)Investor deck25 slidesNov 15, 2011
CryoLife — Merger or Acquisition (March 2011)Merger or acquisition8 slidesMar 29, 2011

Open Decks

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue441.3M388.5M354.0M313.8M298.8M253.2M276.2M262.8M189.7M180.4M
Cost of revenue157.1M139.8M124.8M111.3M101.3M85.4M93.2M89.9M61.1M61.5M
Gross profit284.2M248.8M229.2M202.5M197.5M167.8M183.0M173.0M128.6M118.9M
Research and development31.0M28.5M28.7M38.9M35.5M24.2M23.0M23.1M19.5M13.4M
Selling, general and administrative226.5M181.5M209.0M157.4M169.8M141.1M143.0M140.6M101.2M91.5M
Operating income33.7M38.9M5.74M6.20M8.12M2.44M17.0M9.31M7.97M21.8M
Depreciation and amortization22.5M24.2M23.1M22.4M24.0M20.7M18.3M18.1M9.74M8.38M
EBITDA56.2M63.1M28.8M28.6M32.1M23.2M35.4M27.4M17.7M30.2M
Interest expense26.6M34.3M25.3M18.2M16.9M16.7M14.9M15.8M4.90M3.00M
Income before tax14.8M-7.51M-21.6M-15.0M-14.8M-17.2M1.64M-6.39M3.56M18.4M
Income tax5.01M5.84M9.10M4.21M7.00K-492.0K-76.0K-3.55M-143.0K7.63M
Net income9.77M-13.4M-30.7M-19.2M-14.8M-16.7M1.72M-2.84M3.70M10.8M
Earnings per share, basic0.22-0.32-0.75-0.48-0.38-0.440.05-0.080.110.33
Earnings per share, diluted0.21-0.32-0.75-0.48-0.38-0.440.05-0.080.110.32

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents64.9M53.5M58.9M39.4M55.0M61.4M33.8M41.5M40.0M56.6M
Short-term investments546.0K528.0K747.0K776.0K699.0K
Receivables89.8M79.5M71.8M61.8M53.0M46.0M52.9M47.1M47.5M27.8M
Inventory92.4M79.8M82.0M74.5M77.0M73.0M53.1M45.5M46.7M26.3M
Current assets358.1M290.1M280.7M247.3M247.7M234.6M187.4M179.2M179.3M147.2M
Property, plant and equipment65.0M36.4M38.4M38.7M37.5M33.1M32.1M31.0M33.6M18.5M
Goodwill254.1M241.0M247.3M243.6M250.0M260.1M186.7M188.8M188.3M78.3M
Total assets884.8M789.1M792.4M762.8M793.1M789.4M605.7M571.1M589.7M316.1M
Accounts payable16.0M18.0M13.3M12.0M10.4M9.62M9.80M7.55M9.77M5.74M
Current liabilities101.6M66.8M57.9M49.7M45.0M60.5M45.2M34.5M42.9M30.1M
Long-term debt215.1M314.2M305.5M306.5M307.5M290.5M214.6M215.7M218.2M67.0M
Total debt215.1M314.3M307.0M308.1M309.1M291.7M215.7M216.9M219.0M71.6M
Total liabilities436.6M512.9M510.6M478.5M492.3M460.7M320.0M296.0M312.6M107.2M
Shareholders' equity448.2M276.2M281.8M284.3M300.7M328.7M285.7M275.1M277.1M209.0M
Shares outstanding48.8M48.8M47.9M41.8M42.0M41.2M40.6M40.1M39.0M39.1M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations39.9M22.2M18.8M-5.15M-2.58M12.4M15.8M9.88M10.8M19.7M
Capital spending-39.0M-11.2M-9.75M-10.7M-13.1M-7.33M-8.07M-5.79M-6.63M-6.20M
Free cash flow839.0K11.0M9.07M-15.9M-15.7M5.04M7.75M4.09M4.17M13.5M
Cash from investing-42.0M-28.2M-502.0K-10.7M5.66M-73.1M-23.9M-6.71M-171.0M-78.9M
Cash from financing11.3M2.20M865.0K-1.64M-12.2M93.6M-1.49M-2.56M143.2M73.4M
Dividends paid-3.76M-2.43M-4.76M
Share buybacks00-559.0K-1.79M-1.91M-2.00M-2.74M-2.10M-1.61M-697.0K
Change in cash11.4M-5.48M19.6M-15.7M-6.95M27.7M-7.94M1.48M-16.6M13.9M

Open Financials

Filings

FilingDateTypeFiled with
10-Q · Quarterly reportNov 6, 2026Quarterly reportSEC
8-K · Current reportNov 5, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedOct 27, 2026Big-stake noticeSEC
4 · Change in ownershipSep 11, 2026Insider tradeSEC
144 · Notice of proposed saleSep 10, 2026Other filingsSEC
4 · Change in ownershipSep 4, 2026Insider tradeSEC
144 · Notice of proposed saleSep 3, 2026Other filingsSEC
144 · Notice of proposed saleSep 2, 2026Other filingsSEC
144 · Notice of proposed saleAug 27, 2026Other filingsSEC
4 · Change in ownershipAug 20, 2026Insider tradeSEC
Show 200 filings
FilingDateTypeFiled with
144 · Notice of proposed saleAug 19, 2026Other filingsSEC
4 · Change in ownershipAug 17, 2026Insider tradeSEC
4 · Change in ownershipAug 17, 2026Insider tradeSEC
144 · Notice of proposed saleAug 14, 2026Other filingsSEC
144 · Notice of proposed saleAug 14, 2026Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2026Big-stake noticeSEC
4 · Change in ownershipAug 12, 2026Insider tradeSEC
10-Q · Quarterly reportAug 7, 2026Quarterly reportSEC
8-K · Current reportAug 6, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 6, 2026Big-stake noticeSEC
4 · Change in ownershipJun 15, 2026Insider tradeSEC
144 · Notice of proposed saleJun 11, 2026Other filingsSEC
3 · Initial statement of ownershipJun 8, 2026Insider tradeSEC
4 · Change in ownershipJun 4, 2026Insider tradeSEC
SD · Specialized disclosureMay 21, 2026ESG reportSEC
4/A · Change in ownership, amendedMay 20, 2026Insider tradeSEC
4 · Change in ownershipMay 20, 2026Insider tradeSEC
4 · Change in ownershipMay 20, 2026Insider tradeSEC
4 · Change in ownershipMay 20, 2026Insider tradeSEC
4 · Change in ownershipMay 20, 2026Insider tradeSEC
4 · Change in ownershipMay 20, 2026Insider tradeSEC
4 · Change in ownershipMay 20, 2026Insider tradeSEC
4 · Change in ownershipMay 20, 2026Insider tradeSEC
4 · Change in ownershipMay 19, 2026Insider tradeSEC
8-K · Current reportMay 18, 2026Current reportSEC
8-K · Current reportMay 15, 2026Meeting outcomeSEC
10-Q · Quarterly reportMay 8, 2026Quarterly reportSEC
8-K · Current reportMay 7, 2026ResultsSEC
ARS · Annual report to shareholdersApr 1, 2026Annual reportSEC
DEFA14A · Additional proxy materialApr 1, 2026Meeting noticeSEC
DEF 14A · Proxy statementApr 1, 2026Meeting noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMar 26, 2026Big-stake noticeSEC
4 · Change in ownershipMar 4, 2026Insider tradeSEC
4 · Change in ownershipMar 4, 2026Insider tradeSEC
4 · Change in ownershipMar 4, 2026Insider tradeSEC
4 · Change in ownershipMar 4, 2026Insider tradeSEC
4 · Change in ownershipMar 4, 2026Insider tradeSEC
4 · Change in ownershipMar 4, 2026Insider tradeSEC
144 · Notice of proposed saleMar 4, 2026Other filingsSEC
144 · Notice of proposed saleMar 3, 2026Other filingsSEC
144 · Notice of proposed saleMar 3, 2026Other filingsSEC
144 · Notice of proposed saleMar 3, 2026Other filingsSEC
144 · Notice of proposed saleMar 3, 2026Other filingsSEC
144 · Notice of proposed saleMar 3, 2026Other filingsSEC
144 · Notice of proposed saleMar 3, 2026Other filingsSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
144 · Notice of proposed saleMar 2, 2026Other filingsSEC
144 · Notice of proposed saleMar 2, 2026Other filingsSEC
144 · Notice of proposed saleMar 2, 2026Other filingsSEC
144 · Notice of proposed saleMar 2, 2026Other filingsSEC
144 · Notice of proposed saleMar 2, 2026Other filingsSEC
144 · Notice of proposed saleMar 2, 2026Other filingsSEC
4 · Change in ownershipFeb 25, 2026Insider tradeSEC
4 · Change in ownershipFeb 25, 2026Insider tradeSEC
4 · Change in ownershipFeb 25, 2026Insider tradeSEC
4 · Change in ownershipFeb 25, 2026Insider tradeSEC
4 · Change in ownershipFeb 25, 2026Insider tradeSEC
4 · Change in ownershipFeb 25, 2026Insider tradeSEC
144 · Notice of proposed saleFeb 24, 2026Other filingsSEC
144 · Notice of proposed saleFeb 24, 2026Other filingsSEC
144 · Notice of proposed saleFeb 24, 2026Other filingsSEC
144 · Notice of proposed saleFeb 24, 2026Other filingsSEC
144 · Notice of proposed saleFeb 24, 2026Other filingsSEC
144 · Notice of proposed saleFeb 24, 2026Other filingsSEC
144 · Notice of proposed saleFeb 23, 2026Other filingsSEC
144 · Notice of proposed saleFeb 23, 2026Other filingsSEC
144 · Notice of proposed saleFeb 23, 2026Other filingsSEC
144 · Notice of proposed saleFeb 23, 2026Other filingsSEC
144 · Notice of proposed saleFeb 23, 2026Other filingsSEC
144 · Notice of proposed saleFeb 23, 2026Other filingsSEC
10-K · Annual reportFeb 18, 2026Annual reportSEC
SCHEDULE 13G · Big-stake noticeFeb 17, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 13, 2026Big-stake noticeSEC
8-K · Current reportFeb 12, 2026ResultsSEC
5 · Annual statement of ownershipJan 28, 2026Insider tradeSEC
5 · Annual statement of ownershipJan 28, 2026Insider tradeSEC
5 · Annual statement of ownershipJan 28, 2026Insider tradeSEC
4 · Change in ownershipDec 17, 2025Insider tradeSEC
144 · Notice of proposed saleDec 17, 2025Other filingsSEC
4 · Change in ownershipDec 9, 2025Insider tradeSEC
144 · Notice of proposed saleDec 8, 2025Other filingsSEC
4 · Change in ownershipDec 4, 2025Insider tradeSEC
4 · Change in ownershipDec 4, 2025Insider tradeSEC
4 · Change in ownershipDec 3, 2025Insider tradeSEC
144 · Notice of proposed saleDec 3, 2025Other filingsSEC
144 · Notice of proposed saleDec 3, 2025Other filingsSEC
4 · Change in ownershipDec 2, 2025Insider tradeSEC
144 · Notice of proposed saleDec 2, 2025Other filingsSEC
4 · Change in ownershipNov 24, 2025Insider tradeSEC
4 · Change in ownershipNov 24, 2025Insider tradeSEC
144 · Notice of proposed saleNov 21, 2025Other filingsSEC
144 · Notice of proposed saleNov 20, 2025Other filingsSEC
4 · Change in ownershipNov 19, 2025Insider tradeSEC
144 · Notice of proposed saleNov 18, 2025Other filingsSEC
4 · Change in ownershipNov 18, 2025Insider tradeSEC
4 · Change in ownershipNov 18, 2025Insider tradeSEC
4 · Change in ownershipNov 18, 2025Insider tradeSEC
144 · Notice of proposed saleNov 17, 2025Other filingsSEC
144 · Notice of proposed saleNov 17, 2025Other filingsSEC
144 · Notice of proposed saleNov 17, 2025Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 14, 2025Big-stake noticeSEC
144 · Notice of proposed saleNov 14, 2025Other filingsSEC
4 · Change in ownershipNov 14, 2025Insider tradeSEC
4 · Change in ownershipNov 14, 2025Insider tradeSEC
4 · Change in ownershipNov 14, 2025Insider tradeSEC
4 · Change in ownershipNov 14, 2025Insider tradeSEC
4 · Change in ownershipNov 14, 2025Insider tradeSEC
144 · Notice of proposed saleNov 14, 2025Other filingsSEC
144 · Notice of proposed saleNov 13, 2025Other filingsSEC
144 · Notice of proposed saleNov 13, 2025Other filingsSEC
144 · Notice of proposed saleNov 13, 2025Other filingsSEC
144 · Notice of proposed saleNov 13, 2025Other filingsSEC
144 · Notice of proposed saleNov 13, 2025Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 13, 2025Big-stake noticeSEC
4 · Change in ownershipNov 12, 2025Insider tradeSEC
4 · Change in ownershipNov 12, 2025Insider tradeSEC
4 · Change in ownershipNov 12, 2025Insider tradeSEC
4 · Change in ownershipNov 12, 2025Insider tradeSEC
4 · Change in ownershipNov 12, 2025Insider tradeSEC
144 · Notice of proposed saleNov 12, 2025Other filingsSEC
144 · Notice of proposed saleNov 12, 2025Other filingsSEC
144 · Notice of proposed saleNov 12, 2025Other filingsSEC
144 · Notice of proposed saleNov 12, 2025Other filingsSEC
144 · Notice of proposed saleNov 12, 2025Other filingsSEC
144 · Notice of proposed saleNov 12, 2025Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 7, 2025Big-stake noticeSEC
10-Q · Quarterly reportNov 7, 2025Quarterly reportSEC
8-K · Current reportNov 6, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedOct 17, 2025Big-stake noticeSEC
8-K · Current reportSep 29, 2025Material contractSEC
8-K · Current reportSep 15, 2025Material contractSEC
4 · Change in ownershipAug 28, 2025Insider tradeSEC
144 · Notice of proposed saleAug 27, 2025Other filingsSEC
4 · Change in ownershipAug 26, 2025Insider tradeSEC
144 · Notice of proposed saleAug 25, 2025Other filingsSEC
4 · Change in ownershipAug 19, 2025Insider tradeSEC
144 · Notice of proposed saleAug 15, 2025Other filingsSEC
4 · Change in ownershipAug 14, 2025Insider tradeSEC
4 · Change in ownershipAug 14, 2025Insider tradeSEC
144 · Notice of proposed saleAug 12, 2025Other filingsSEC
144 · Notice of proposed saleAug 12, 2025Other filingsSEC
SCHEDULE 13D/A · Big-stake notice, amendedAug 12, 2025Big-stake noticeSEC
4 · Change in ownershipAug 11, 2025Insider tradeSEC
8-K · Current reportAug 11, 2025Management or board changeSEC
144 · Notice of proposed saleAug 8, 2025Other filingsSEC
S-8 · Registration statement for employee plansAug 8, 2025Offer documentSEC
10-Q · Quarterly reportAug 8, 2025Quarterly reportSEC
8-K · Current reportAug 7, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 6, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedJul 21, 2025Big-stake noticeSEC
4 · Change in ownershipJun 18, 2025Insider tradeSEC
144 · Notice of proposed saleJun 17, 2025Other filingsSEC
4 · Change in ownershipJun 16, 2025Insider tradeSEC
144 · Notice of proposed saleJun 13, 2025Other filingsSEC
8-K · Current reportMay 28, 2025FinancingSEC
4 · Change in ownershipMay 27, 2025Insider tradeSEC
4/A · Change in ownership, amendedMay 27, 2025Insider tradeSEC
4 · Change in ownershipMay 27, 2025Insider tradeSEC
144 · Notice of proposed saleMay 27, 2025Other filingsSEC
4 · Change in ownershipMay 27, 2025Insider tradeSEC
4 · Change in ownershipMay 27, 2025Insider tradeSEC
4 · Change in ownershipMay 27, 2025Insider tradeSEC
4 · Change in ownershipMay 27, 2025Insider tradeSEC
4 · Change in ownershipMay 27, 2025Insider tradeSEC
4 · Change in ownershipMay 27, 2025Insider tradeSEC
4 · Change in ownershipMay 27, 2025Insider tradeSEC
4 · Change in ownershipMay 27, 2025Insider tradeSEC
144 · Notice of proposed saleMay 23, 2025Other filingsSEC
144 · Notice of proposed saleMay 21, 2025Other filingsSEC
144 · Notice of proposed saleMay 21, 2025Other filingsSEC
4 · Change in ownershipMay 21, 2025Insider tradeSEC
SD · Specialized disclosureMay 19, 2025ESG reportSEC
8-K · Current reportMay 16, 2025Meeting outcomeSEC
8-K · Current reportMay 14, 2025FinancingSEC
4 · Change in ownershipMay 12, 2025Insider tradeSEC
SCHEDULE 13G · Big-stake noticeMay 12, 2025Big-stake noticeSEC
144 · Notice of proposed saleMay 9, 2025Other filingsSEC
10-Q · Quarterly reportMay 6, 2025Quarterly reportSEC
8-K · Current reportMay 5, 2025ResultsSEC
ARS · Annual report to shareholdersApr 1, 2025Annual reportSEC
DEFA14A · Additional proxy materialApr 1, 2025Meeting noticeSEC
DEF 14A · Proxy statementApr 1, 2025Meeting noticeSEC
4 · Change in ownershipMar 12, 2025Insider tradeSEC
4 · Change in ownershipMar 12, 2025Insider tradeSEC
144 · Notice of proposed saleMar 11, 2025Other filingsSEC

This page holds 200 of 1,000 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Artivion, Inc.’s releases · as of Oct 30, 2026

Common shares
48,789,772
Fully diluted
48,789,772

Fully diluted

LineSharesAs of
Common shares48,789,772Oct 30, 2026

Share count over time

CountShares
Oct 30, 202648,789,772

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueChange vs Jun 30Filed
BlackRock7.35M15.1%US$168M+674KNov 13, 2026
Vanguard3.41M7.0%US$77.7M+48,103Nov 13, 2026
Nomura3.17M6.5%US$72.3M−18,045Nov 16, 2026
Morgan Stanley2.65M5.4%US$60.4M+87,282Nov 13, 2026
Perceptive Advisors LLC2.11M4.3%US$48.2M+375KNov 16, 2026
Juniper Investment Company, LLC2.02M4.1%US$46.1MNo changeNov 16, 2026
State Street1.99M4.1%US$45.5M+135KNov 12, 2026
Ophir Asset Management Pty Ltd1.67M3.4%US$38.2M−127KNov 16, 2026
Conestoga Capital Advisors, LLC1.37M2.8%US$31.3M−254KNov 2, 2026
GW&K Investment Management, LLC1.33M2.7%US$30.4M+538KNov 10, 2026
Show 50 holders
HolderSharesOf the companyValueChange vs Jun 30Filed
Geode Capital1.19M2.4%US$27.2M+77,066Nov 6, 2026
Wellington1.18M2.4%US$26.8M−85,058Nov 16, 2026
Citadel1.14M2.3%US$26.1M+316KNov 16, 2026
Goldman Sachs1.04M2.1%US$23.7M+599KNov 16, 2026
Dimensional1.02M2.1%US$23.3M+72,764Nov 4, 2026
Fred Alger Management, LLC937K1.9%US$21.4M+474KNov 16, 2026
Silvercrest Asset Management Group LLC931K1.9%US$21.3M−92,639Nov 16, 2026
Royce & Associates LP890K1.8%US$20.3M+250KNov 9, 2026
Bank of America587K1.2%US$13.4M+65,431Nov 16, 2026
Yarger Wealth Strategies, LLC564K1.2%US$12.9M−70,000Nov 10, 2026
Millennium559K1.1%US$12.8MNewNov 16, 2026
Northern Trust552K1.1%US$12.6M+1,897Nov 16, 2026
abrdn521K1.1%US$11.9MNewNov 10, 2026
D. E. Shaw & Co., Inc.495K1.0%US$11.3M+57,007Nov 16, 2026
Schwab491K1.0%US$11.2M+82,222Nov 16, 2026
SG Capital Management LLC484K0.99%US$11MNewNov 6, 2026
UBS411K0.84%US$9.38M−107KNov 16, 2026
First Eagle Investment Management, LLC378K0.77%US$8.62M−316KNov 10, 2026
Principal337K0.69%US$7.7M+83,415Nov 2, 2026
Champlain Investment Partners, LLC292K0.60%US$6.66MNewNov 12, 2026
Legal & General283K0.58%US$6.45M+23,453Nov 16, 2026
BNY265K0.54%US$6.05M+12,663Nov 5, 2026
Public Sector Pension Investment Board244K0.50%US$5.31M+97,692Nov 10, 2026
Osterweis Capital Management Inc220K0.45%US$5.02MNewNov 16, 2026
Kennedy Capital Management LLC207K0.42%US$4.71M−87,675Nov 13, 2026
Tidal Investments LLC193K0.40%US$4.4M+6,680Nov 13, 2026
Orbimed Advisors LLC175K0.36%US$3.99MNo changeNov 16, 2026
Fifth Third Bancorp174K0.36%US$3.98M−11,130Nov 5, 2026
Quantinno Capital Management LP171K0.35%US$3.91M−29,014Nov 13, 2026
Invesco158K0.32%US$3.6M−286KNov 12, 2026
Russell Investments Group, Ltd.120K0.25%US$2.75M+10,426Nov 6, 2026
Connors Investor Services Inc118K0.24%US$2.69M−2,210Nov 19, 2026
Summit Creek Advisors LLC117K0.24%US$2.68M−2,980Nov 3, 2026
Corient Private Wealth LP108K0.22%US$2.46M−51,593Nov 16, 2026
Nuveen106K0.22%US$2.42M−2,667Nov 10, 2026
Wilshire Advisors LLC106K0.22%US$2.41MNewNov 12, 2026
Rhumbline Advisers106K0.22%US$2.41M+54Nov 10, 2026
Ameriprise102K0.21%US$2.34M−91,111Nov 16, 2026
Parkman Healthcare Partners LLC101K0.21%US$2.31M−37,610Nov 16, 2026
Tocqueville Asset Management L.P.100K0.20%US$2.28M+75,000Nov 13, 2026

This page holds 50 of 210 holders. Open Shareholders

Funds

HolderSharesOf the companyValueChangeAs of
iShares Core S&P Small-Cap ETF2.57M5.3%US$57.8M+47,780Jun 30, 2026
Nomura Small Cap Core Fund1.74M3.6%US$38.5M+202KMay 29, 2026
Vanguard Total Stock Market Index Fund1.46M3.0%US$32.9M+30,981Jun 30, 2026
iShares Russell 2000 ETF1.19M2.4%US$26.7M+122KJun 30, 2026
Conestoga Small Cap Fund963K2.0%US$21.6M+235KJun 30, 2026
Fidelity Small Cap Value Fund611K1.3%US$16.4MNewJul 31, 2026
Nomura Small Cap Growth Fund548K1.1%US$12.3M+226KJun 30, 2026
Fidelity Small Cap Growth Fund533K1.1%US$14.3MNo changeJul 31, 2026
Fidelity Stock Selector Small Cap Fund511K1.0%US$13.7M+79,600Jul 31, 2026
Fidelity Small Cap Index Fund499K1.0%US$13.4M+67,368Jul 31, 2026
Show 50 holders
HolderSharesOf the companyValueChangeAs of
Vanguard Extended Market Index Fund495K1.0%US$11.1M+24,072Jun 30, 2026
iShares Russell 2000 Growth ETF429K0.88%US$9.65M+140KJun 30, 2026
State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF391K0.80%US$8.77M+6,454Jun 30, 2026
iShares S&P Small-Cap 600 Growth ETF383K0.78%US$8.6M+20,659Jun 30, 2026
First Eagle Small Cap Opportunity Fund323K0.66%US$8.65M+28,195Jul 31, 2026
Fidelity Series Small Cap Opportunities Fund293K0.60%US$7.86M−10,000Jul 31, 2026
Fidelity Small Cap Growth K6 Fund265K0.54%US$7.12MNo changeJul 31, 2026
Vanguard Tax-Managed Small-Cap Fund256K0.53%US$5.76MNo changeJun 30, 2026
Alger Weatherbie Specialized Growth Fund256K0.52%US$6.86M−42,634Jul 31, 2026
Fidelity Advisor Small Cap Fund250K0.51%US$5.54MNo changeMay 31, 2026
Invesco S&P SmallCap Momentum ETF245K0.50%US$6.57M+49,677Jul 31, 2026
State Street(R) SPDR(R) S & P 600(TM) Small Cap Growth ETF241K0.49%US$5.41M+18,679Jun 30, 2026
Vanguard Russell 2000 Index Fund224K0.46%US$4.98M+15,568May 31, 2026
Fidelity Extended Market Index Fund218K0.45%US$4.83M+1,660May 31, 2026
U.S. Small Cap Portfolio213K0.44%US$5.71M+7,168Jul 31, 2026
Schwab U.S. Small-Cap ETF201K0.41%US$4.46M−589May 31, 2026
iShares U.S. Medical Devices ETF200K0.41%US$4.49M+18,993Jun 30, 2026
Royce Small-Cap Opportunity Fund198K0.40%US$4.44M+91,087Jun 30, 2026
Unusual Whales Subversive Democratic Trading ETF186K0.38%US$4.18M−2,505Jun 30, 2026
AMG GW&K Small Cap Core Fund166K0.34%US$3.73M−3,741Jun 30, 2026
U.S. Micro Cap Portfolio165K0.34%US$4.44M+2,445Jul 31, 2026
Wasatch Ultra Growth Fund152K0.31%US$3.43MNo changeJun 30, 2026
Vanguard S&P Small-Cap 600 Index Fund145K0.30%US$3.23M+2,378May 31, 2026
Dimensional U.S. Small Cap ETF125K0.26%US$3.35M−33,445Jul 31, 2026
State Street(R) SPDR(R) S&P(R) Health Care Equipment ETF121K0.25%US$2.73M+56,685Jun 30, 2026
Vanguard Health Care Index Fund120K0.25%US$2.67M−322May 31, 2026
NYLIM WMC Small Companies Fund113K0.23%US$3.04M−2,008Jul 31, 2026
Schwab Small-Cap Index Fund111K0.23%US$2.97M+14,383Jul 31, 2026
Nomura VIP Small Cap Growth Series107K0.22%US$2.41M+46,091Jun 30, 2026
Multi-Manager Small Cap Equity Strategies Fund107K0.22%US$2.36M+94,460May 31, 2026
SFT Nomura Small Cap Growth Fund90,7030.19%US$2.04M+39,016Jun 30, 2026
Dimensional U.S. Core Equity 2 ETF90,0380.18%US$2.42M−17,372Jul 31, 2026
AMG GW&K Small Cap Growth Fund89,9520.18%US$2.41M+31,785Jul 31, 2026
abrdn U.S. Small Cap Equity Fund87,0150.18%US$2.33MNewJul 31, 2026
Master Small Cap Index Series85,4810.18%US$1.92M+16,252Jun 30, 2026
Fidelity Total Market Index Fund80,4490.16%US$1.79M+3,053May 31, 2026
U.S. Core Equity 2 Portfolio70,9020.15%US$1.9M−16,439Jul 31, 2026
Vanguard Strategic Equity Fund70,1760.14%US$1.58MNo changeJun 30, 2026
JNL Small Cap Index Fund66,9310.14%US$1.5M+2,399Jun 30, 2026
Royce Micro-Cap Fund64,9620.13%US$1.46MNo changeJun 30, 2026

This page holds 50 of 222 holders. Open Shareholders

Insider trades

InsiderTradeSharesPriceValueDate
Green Andrew M
Officer: SVP, Regulatory and Quality
Sale11,480USD 24.97US$287KSep 10, 2026
Green Andrew M
Officer: SVP, Regulatory and Quality
Sale1,493USD 26.02US$38,848Sep 3, 2026
Green Andrew M
Officer: SVP, Regulatory and Quality
Sale6,510USD 27.27US$178KSep 2, 2026
Mackin James P
Officer: President & CEO
Sale70,000USD 28.96US$2.03MAug 19, 2026
Berry Lance A
Officer: EVP, COO, CFO & Treasurer
Sale715USD 28.55US$20,413Aug 14, 2026
Green Andrew M
Officer: SVP, Regulatory and Quality
Sale616USD 28.55US$17,587Aug 14, 2026
Holloway Jean F
Officer: SVP, General Counsel
Sale977USD 28.49US$27,835Aug 12, 2026
Green Andrew M
Officer: SVP, Regulatory and Quality
Sale14,001USD 20.71US$290KJun 11, 2026
Green Andrew M
Officer: SVP, Regulatory and Quality
Sale30,000USD 20.69US$621KJun 11, 2026

Big stakes

HolderStakeSharesDate
BlackRock, Inc.14.70%7.16MSep 30, 2026
Nomura Asset Management International Inc.6.50%3.18MJun 30, 2026
Juniper Investment Company, LLC4.00%1.86MAug 8, 2025

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Lance Berry
Other companies: Treace Medical Concepts, Inc. (Board Member · Since at least Oct 1, 2022); AEON Biopharma, Inc. (Director · Feb 8, 2021 – Feb 8, 2021 · Past); Vapotherm Inc (Director · Jan 29, 2020 – Sep 20, 2024 · Past); Wright Medical Group N.V (EVP, Chief Fin & Op Officer · Oct 1, 2015 – Nov 11, 2020 · Past)
Executive Vice President, Chief Operating Officer, and Chief Financial Officer · Since at least Dec 6, 2023
Philip A Theodore
Other companies: Medizone International Inc (Executive Vice President · Nov 1, 2017 – Jan 3, 2018 · Past); Zep Inc (VP & General Counsel · Jul 19, 2010 – Oct 1, 2014 · Past); Harland John H Co (SVP, General Counsel · Sep 5, 2006 – May 1, 2007 · Past); Serologicals Corp (Vice President · Jul 14, 2006 – Jul 14, 2006 · Past)
VP, General Counsel · Sep 4, 2007 – Sep 4, 2007 · Past
Harvey Morgan
Other companies: Family Dollar Stores Inc (Director · Nov 5, 2007 – Jul 6, 2015 · Past); Cybex International Inc (Director · Jan 9, 2006 – Feb 7, 2013 · Past)
Director · May 1, 2008 – Aug 30, 2021 · Past
Jon W Salveson
Other companies: Nuwellis, Inc. (Director · Mar 13, 2013 – May 19, 2023 · Past); Piper Sandler Companies (Global Head of Invest. Banking · Aug 11, 2006 – Feb 16, 2010 · Past)
Director · Since at least May 16, 2012
James Benson
Other companies: Nuo Therapeutics Inc (Director · Jan 12, 2006 – Mar 19, 2013 · Past)
Director · May 5, 2006 – Oct 2, 2017 · Past
James P Mackin
Other companies: Wright Medical Group N.V (Director · Jun 29, 2018 – Nov 11, 2020 · Past)
President & CEO · Since at least Sep 2, 2014
Jason Asper
Other companies: Wright Medical Group N.V (SVP, Chief Digital Officer · Aug 14, 2017 – Nov 11, 2020 · Past)
Senior Vice President and Chief Strategy and Digital Officer · Since at least Nov 4, 2026
Jeff Burbank
Other companies: NxStage Medical Inc (Chief Executive Officer, Director · Jun 8, 2006 – Feb 21, 2019 · Past)
Lead Director · Since at least Dec 18, 2017
Jeffrey W Burris
Other companies: Supernus Pharmaceuticals, Inc. (Chief Legal Officer · Since at least Jan 1, 2026)
Vice President & Gen. Counsel · Feb 16, 2010 – Aug 15, 2014 · Past
Thomas F. Ackerman
Other companies: Charles River Laboratories International, Inc. (Corporate Executive VP & CFO · Feb 17, 2006 – May 15, 2015 · Past)
Executive Vice President and Chief Financial Officer · Since at least May 5, 2006
All 50 people
PersonSeat
Albert E HeacoxSr. VP Research and Devl · Feb 21, 2006 – Dec 31, 2011 · Past
Amy D. HortonVice President, Chief Accounting Officer · Since at least Jun 5, 2019
Andrew M. GreenSenior Vice President, Regulatory and Quality · Since at least Mar 8, 2021
Anthony SemedoDirector · Since at least Oct 1, 2021
Brian JohnstonExecutive Vice President · Since at least Oct 28, 2026
Bruce G AndersonVP, US Sales &Global Marketing · Dec 10, 2012 – Mar 7, 2015 · Past
Carlos SotoVice President, Global Manufacturing · Since at least Nov 4, 2026
C Elkins RonaldDirector · May 5, 2006 – Sep 5, 2018 · Past
Daniel J. BevevinoDirector · Since at least May 5, 2006
David Ashley LeeExecutive VP, COO & CFO · Feb 21, 2006 – Mar 1, 2023 · Past
David C GaleVP, Research & Development · Jan 1, 2012 – Nov 16, 2017 · Past
David FronkVP, Regulatory Affairs · Dec 31, 2005 – Mar 7, 2015 · Past
David P LangVP, Int'l Sales & Marketing · Dec 10, 2012 – Feb 26, 2015 · Past
Dennis B MaierSVP, Operations · May 25, 2018 – Jun 6, 2023 · Past
Elizabeth A. HoffConsultant and Founder · Since at least Oct 1, 2022
Florian TyrsVP, Global Operations · Jun 23, 2023 – Feb 27, 2024 · Past
Franz Peter BartholdVP, Research & Development · Jul 1, 2020 – Nov 8, 2022 · Past
Gerald B SeerySr. VP, Sales and Marketing · Feb 21, 2006 – Nov 30, 2012 · Past
James BullockDirector · Since at least Nov 8, 2016
Jean F. HollowaySenior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary · Since at least Apr 1, 2015
Jim BullockSince at least May 20, 2026
John E. DavisChief Commercial Officer · Since at least Sep 10, 2015
John M CookDirector · May 5, 2006 – Jun 9, 2009 · Past
Jon W. SalvesonVice Chairman, Investment Banking · Since at least May 20, 2026
J. Patrick MackinChairman, President and Chief Executive Officer · Since at least Nov 4, 2026
Marna P. BorgstromChief Executive Officer · Since at least Jun 19, 2018
Marshall S StantonSVP, Clinical & MD Affair · Since at least Mar 8, 2021
Matthew A. GetzVice President, Chief Human Resources Officer · Since at least Jul 31, 2019
Michael S SimpsonSVP, Regulatory Affairs and QA · Dec 3, 2018 – Mar 5, 2021 · Past
Robert C. ThomsonVice President, Research and Development · Since at least Jun 8, 2023
Rochelle L. ManeyVice President, Global Quality · Since at least Mar 8, 2021
Ronald D McCallDirector · Jan 3, 2006 – Aug 25, 2021 · Past
Scott B CappsVP, Clinical Research · Oct 29, 2007 – Mar 12, 2021 · Past
Sherry M SauriniVP, Quality · Feb 19, 2016 – Mar 14, 2019 · Past
Sidney B AshmoreVice President of Marketing · Jan 18, 2006 – Jan 18, 2006 · Past
Simona ZannettiSenior Vice President of Clinical Research and Chief Medical Officer · Since at least Nov 4, 2026
Steven G AndersonFormer Executive Chairman · Nov 18, 2011 – Apr 9, 2015 · Past
Thomas J BogenschuetzVP, EMEA & General Manager · May 25, 2018 – May 5, 2020 · Past
Virginia C LacyDirector · May 5, 2006 – Apr 24, 2007 · Past
William Robert MatthewsSenior VP, Operations, Quality · Sep 13, 2016 – Mar 5, 2018 · Past

Open People

Log in to ask 6ix AI your own questions about Artivion, Inc.